Aberrant SERPINE1 DNA methylation is involved in carboplatin induced epithelial-mesenchymal transition in epithelial ovarian cancer.
Pan, Jie-Xue
Aberrant SERPINE1 DNA methylation is involved in carboplatin induced epithelial-mesenchymal transition in epithelial ovarian cancer. [electronic resource] - Archives of gynecology and obstetrics Dec 2017 - 1145-1152 p. digital
Publication Type: Journal Article
1432-0711
10.1007/s00404-017-4547-x doi
Antigens, CD
Antineoplastic Agents
Cadherins--metabolism
Carboplatin--pharmacology
Carcinoma, Ovarian Epithelial
Cell Line, Tumor
DNA Methylation
Drug Resistance, Neoplasm
Epithelial-Mesenchymal Transition--drug effects
Female
Humans
Neoplasms, Glandular and Epithelial--drug therapy
Ovarian Neoplasms--drug therapy
Plasminogen Activator Inhibitor 1--genetics
Promoter Regions, Genetic
Serpin E2
Aberrant SERPINE1 DNA methylation is involved in carboplatin induced epithelial-mesenchymal transition in epithelial ovarian cancer. [electronic resource] - Archives of gynecology and obstetrics Dec 2017 - 1145-1152 p. digital
Publication Type: Journal Article
1432-0711
10.1007/s00404-017-4547-x doi
Antigens, CD
Antineoplastic Agents
Cadherins--metabolism
Carboplatin--pharmacology
Carcinoma, Ovarian Epithelial
Cell Line, Tumor
DNA Methylation
Drug Resistance, Neoplasm
Epithelial-Mesenchymal Transition--drug effects
Female
Humans
Neoplasms, Glandular and Epithelial--drug therapy
Ovarian Neoplasms--drug therapy
Plasminogen Activator Inhibitor 1--genetics
Promoter Regions, Genetic
Serpin E2